Science and Research

Deterioration of quality of life is associated with the exacerbation frequency in individuals with alpha-1-antitrypsin deficiency - analysis from the German Registry

BACKGROUND: Alpha-1-antitrypsin deficiency (AATD) is a rare hereditary disease that is associated with a higher risk to develop chronic obstructive pulmonary disease and liver cirrhosis. Previous cross-sectional studies on AATD individuals have shown a relationship between worse St George's Respiratory Questionnaire (SGRQ) scores and elevated exacerbation rate or high cigarette consumption. There is a lack of longitudinal data on the relationship between the exacerbation rate and worsening of SGRQ during disease. The aim of this study was to provide not only cross-sectional data but also information about the deterioration in quality of life over a follow-up period up to 7 years (median follow-up period of 3.33 years). METHODS: We investigated questionnaire-based data of the German AATD registry concerning the relationship between SGRQ and exacerbation frequency, smoking history, forced expiratory volume in 1 second (FEV1) and carbon monoxide diffusion capacity (DLCO) first in cross-sectional analysis and later in longitudinal analysis. RESULTS: Eight hundred sixty-eight individuals with protease inhibitor ZZ (PiZZ) genotype with an average age of 52.6+/-12.8 years had an SGRQ score of 45.7+/-20.6. SGRQ significantly correlated with the exacerbation frequency within the last 2 years (r=0.464; P<0.001), smoking history (r=0.233; P<0.001), FEV1 (r=-0.436; P<0.001), DLCO (r=-0.333; P<0.001), and patients' age (r=0.292; P<0.001). Individuals with occupational dust exposure had significantly worse quality of life (P<0.001). Mean annual deterioration of SGRQ in all patients with available follow-up data (n=286) was 1.21+/-4.45 points per year. Univariate and multivariate analysis showed a significant relationship between worsening of SGRQ/year and exacerbation frequency in the follow-up period (r=0.144; P=0.015). CONCLUSION: Worsening of SGRQ is associated with the exacerbation frequency in individuals with PiZZ AATD.
  • Bernhard, N.
  • Lepper, P. M.
  • Vogelmeier, C.
  • Seibert, M.
  • Wagenpfeil, S.
  • Bals, R.
  • Fahndrich, S.

Keywords

  • Adult
  • Aged
  • Cross-Sectional Studies
  • Disease Progression
  • Female
  • Forced Expiratory Volume
  • Germany/epidemiology
  • Humans
  • Linear Models
  • Longitudinal Studies
  • Lung/*physiopathology
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Pulmonary Diffusing Capacity
  • Pulmonary Disease, Chronic
  • Obstructive/diagnosis/epidemiology/physiopathology/*psychology
  • *Quality of Life
  • Registries
  • Risk Factors
  • Smoking/adverse effects
  • Surveys and Questionnaires
  • Time Factors
  • alpha 1-Antitrypsin Deficiency/diagnosis/epidemiology/physiopathology/*psychology
  • Aatd
  • Copd
  • Fev1
  • Sgrq
  • alpha-1-antitrypsin deficiency
  • emphysema
  • exacerbations
  • quality of life
  • from Talecris/Grifols and CSL Behring. CV has received honoraria for speaking
  • engagements and for chairing a research prize committee from Talecris/Grifols.
  • PML has received speaker fees from Talecris/Grifols. The authors report no other
  • conflicts of interest in this work.
Publication details
DOI: 10.2147/COPD.S130925
Journal: International journal of chronic obstructive pulmonary disease
Pages: 1427-1437 
Work Type: Original
Location: Assoziierter Partner, UGMLC
Disease Area: COPD
Partner / Member: COSYCONET, UMR
Access-Number: 28553095
See publication on PubMed

DZL Engagements

chevron-down